These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 19306385

  • 21. Cardiovascular risk screening before starting stimulant medications and prescribing practices of canadian physicians: impact of the Health Canada advisory.
    Conway J, Wong KK, O'Connell C, Warren AE.
    Pediatrics; 2008 Oct; 122(4):e828-34. PubMed ID: 18829780
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and management of sudden death in children.
    Fish FA, Kannankeril PJ.
    Curr Opin Pediatr; 2012 Oct; 24(5):592-602. PubMed ID: 22954955
    [Abstract] [Full Text] [Related]

  • 23. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 24. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
    Eggertson L.
    CMAJ; 2005 Mar 29; 172(7):865. PubMed ID: 15758187
    [No Abstract] [Full Text] [Related]

  • 25. Electrocardiograms for attention deficit disorder.
    Moodie DS.
    Congenit Heart Dis; 2008 Mar 29; 3(5):307. PubMed ID: 18837807
    [No Abstract] [Full Text] [Related]

  • 26. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun 29; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 27. [Safety of drugs to treat attention deficit disorder with hyperactivity].
    Péluchon R.
    Soins Pediatr Pueric; 2012 Jun 29; (268):9. PubMed ID: 23074795
    [No Abstract] [Full Text] [Related]

  • 28. Cardiovascular effects of methylphenidate.
    Daniels SR.
    J Pediatr; 2009 Jul 29; 155(1):A3. PubMed ID: 19559283
    [No Abstract] [Full Text] [Related]

  • 29. Hyperactivity really IS common...and a new warning about treatment.
    Child Health Alert; 2005 Nov 29; 23():3. PubMed ID: 16416539
    [No Abstract] [Full Text] [Related]

  • 30. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2012 Mar 29; 50(3):11-2. PubMed ID: 22390784
    [No Abstract] [Full Text] [Related]

  • 31. Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.
    Silva RR, Skimming JW, Muniz R.
    Clin Pediatr (Phila); 2010 Sep 29; 49(9):840-51. PubMed ID: 20693523
    [Abstract] [Full Text] [Related]

  • 32. Authentic faux diamonds and attention deficit disorder.
    Anijar K, Gabbard D.
    Am J Bioeth; 2005 Sep 29; 5(3):67-70. PubMed ID: 16006371
    [No Abstract] [Full Text] [Related]

  • 33. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 34. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL, Jhung MA, Budnitz DS.
    N Engl J Med; 2006 May 25; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract] [Full Text] [Related]

  • 35. To box OR NOT TO box.
    Newstadt M.
    J Ky Med Assoc; 2006 Aug 25; 104(8):344-5. PubMed ID: 16939037
    [No Abstract] [Full Text] [Related]

  • 36. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL, American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee, American Heart Association Council on Cardiovascular Nursing.
    Circulation; 2008 May 06; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of attention-deficit/hyperactivity disorder.
    Pierce K.
    Pediatr Ann; 2011 Nov 06; 40(11):556-62. PubMed ID: 22066507
    [No Abstract] [Full Text] [Related]

  • 38. Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications.
    Thomas PE, Carlo WF, Decker JA, Cannon BC, Kertesz NJ, Friedman RA, Kim JJ.
    Arch Pediatr Adolesc Med; 2011 Feb 06; 165(2):166-70. PubMed ID: 21300657
    [Abstract] [Full Text] [Related]

  • 39. Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.
    Poulton A, Nanan R.
    Pediatrics; 2008 Jul 06; 122(1):221; author reply 221-2. PubMed ID: 18596017
    [No Abstract] [Full Text] [Related]

  • 40. What exactly are the benefits of stimulants for ADHD?
    Advokat C.
    J Atten Disord; 2009 May 06; 12(6):495-8. PubMed ID: 19380518
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.